Friday, August 22, 2025

Aignostics & Mayo Clinic Unveil Pathology Model Results

Related stories

EdgeConneX & Lambda to Build AI Factory in Chicago

EdgeConneX, a global leader in Build-to-Suit and Build-to-Density data...

Brainbase Labs Uses AWS to Launch Kafka AI Workforce Platform

Brainbase Labs announced the launch of Kafka Workforce, the...

Accenture Backs CLIKA to Expand Edge AI Capabilities

Accenture, through Accenture Ventures, has made a strategic investment...

MANTECH & Oracle Partner on Cost-Efficient AI Cloud for Government

MANTECH, a leading provider of AI and mission-critical technology...
spot_imgspot_img

Aignostics announced research results for a new pathology foundation model developed in collaboration with Mayo Clinic Digital Pathology. The model, built in two months using 1.2 million diverse slide images from Mayo Clinic and Charité – Universitätsmedizin Berlin, establishes a new state-of-the-art for performance across more than twenty public benchmarks. In addition, the model is computationally efficient, enhancing its usability relative to existing image-based models. High performance and efficiency were enabled by Aignostics’ pathologist-curated development approach, which emphasizes the integration of expert medical knowledge throughout the model development process.

“These results represent an exciting achievement in our collaboration with Mayo Clinic,” said Maximilian Alber, CTO of Aignostics. “Aignostics and Mayo Clinic have direct access to millions of additional training images and new data modalities that will be integrated into the model over time, further enhancing its capabilities and accuracy.”

Also Read: Innovaccer Raises $275M in Series F for Healthcare Cloud Expansion

Healthcare and life sciences organizations will be able to use the new model for research and clinical development. Aignostics will also integrate the model into its expanding portfolio of AI-powered pathology products, enabling accurate, generalizable solutions for biomarker, cell, and tissue image analysis. This dual approach – direct licensing of foundational technology and offering purpose-built applications – will allow partner organizations to leverage the model’s capabilities in ways that best suit their specific needs.

“Mayo Clinic Digital Pathology will work with Aignostics to transform pathology for the benefit of patients everywhere,” said Jim Rogers, CEO, Mayo Clinic Digital Pathology. “These results show there is real potential in combining Mayo Clinic’s vast medical expertise and resources with Aignostics’ pioneering technologies,” added Viktor Matyas, CEO of Aignostics. “They underline our ambition and readiness to jointly lead in this space.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img